Benzinga | Dec 7, 2021 10:01AM EST

Pfizer To Host Webcast For Investment Analysts Dec. 17 At 8:30 a.m. EST To Discuss Co., BioNTech's COVID-19 Vaccine, Co.'s Oral Antiviral Treatment Candidate

Pfizer Inc. (NYSE:PFE) invites investors and the general public to access a live webcast of a presentation and conference call with investment analysts at 8:30 a.m. EST on Friday, December 17, 2021. Pfizer Vaccines and Hospital leadership will discuss the Pfizer-BioNTech COVID-19 vaccine and Pfizer's novel COVID-19 oral antiviral treatment candidate.

To access the webcast and presentation slides, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance.

Participants will also have an opportunity to ask questions in a live Q&A session with leadership. Those participants who would like to ask a question can dial either (833) 708-1779 in the United States and Canada or (602) 585-9859 outside of the United States and Canada. The passcode is "121621".

The transcript and webcast replay will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live webcast and will be accessible for at least 90 days.